Clinical lessons learned from the first leg of the CAR T cell journey von Majzner, Robbie G., Mackall, Crystal L.

Volltext

Tumor Antigen Escape from CAR T-cell Therapy von Majzner, Robbie G, Mackall, Crystal L

Volltext

Programming CAR-T cells to kill cancer von Labanieh, Louai, Majzner, Robbie G., Mackall, Crystal L.

Volltext

Harnessing the Immunotherapy Revolution for the Treatment of Childhood Cancers von Majzner, Robbie G., Heitzeneder, Sabine, Mackall, Crystal L.

Volltext

Immunotherapy of Neuroblastoma: Facts and Hopes von Anderson, John, Majzner, Robbie G, Sondel, Paul M

Volltext

CAR T Cell Therapy for Neuroblastoma von Richards, Rebecca M, Sotillo, Elena, Majzner, Robbie G

Volltext

Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors von Theruvath, Johanna, Sotillo, Elena, Mount, Christopher W., Graef, Claus Moritz, Delaidelli, Alberto, Heitzeneder, Sabine, Labanieh, Louai, Dhingra, Shaurya, Leruste, Amaury, Majzner, Robbie G., Xu, Peng, Mueller, Sabine, Yecies, Derek W., Finetti, Martina A., Williamson, Daniel, Johann, Pascal D., Kool, Marcel, Pfister, Stefan, Hasselblatt, Martin, Frühwald, Michael C., Delattre, Olivier, Surdez, Didier, Bourdeaut, Franck, Puget, Stephanie, Zaidi, Sakina, Mitra, Siddhartha S., Cheshier, Samuel, Sorensen, Poul H., Monje, Michelle, Mackall, Crystal L.

Volltext

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours von Flugel, Christian L., Majzner, Robbie G., Krenciute, Giedre, Dotti, Gianpietro, Riddell, Stanley R., Wagner, Dimitrios L., Abou-el-Enein, Mohamed

Volltext

Novel NanoLuc substrates enable bright two-population bioluminescence imaging in animals von Su, Yichi, Walker, Joel R., Park, Yunhee, Smith, Thomas P., Liu, Lan Xiang, Hall, Mary P., Labanieh, Louai, Hurst, Robin, Wang, David C., Encell, Lance P., Kim, Namdoo, Zhang, Feijie, Kay, Mark A., Casey, Kerriann M., Majzner, Robbie G., Cochran, Jennifer R., Mackall, Crystal L., Kirkland, Thomas A., Lin, Michael Z.

Volltext

Potent antitumor efficacy of anti-GD2 CAR T cells in H3-K27M+ diffuse midline gliomas von Mount, Christopher W., Majzner, Robbie G., Sundaresh, Shree, Arnold, Evan P., Kadapakkam, Meena, Haile, Samuel, Labanieh, Louai, Hulleman, Esther, Woo, Pamelyn J., Rietberg, Skyler P., Vogel, Hannes, Monje, Michelle, Mackall, Crystal L.

Volltext

Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling von Weber, Evan W., Parker, Kevin R., Sotillo, Elena, Lynn, Rachel C., Anbunathan, Hima, Lattin, John, Good, Zinaida, Belk, Julia A., Daniel, Bence, Klysz, Dorota, Malipatlolla, Meena, Xu, Peng, Bashti, Malek, Heitzeneder, Sabine, Labanieh, Louai, Vandris, Panayiotis, Majzner, Robbie G., Qi, Yanyan, Sandor, Katalin, Chen, Ling-Chun, Prabhu, Snehit, Gentles, Andrew J., Wandless, Thomas J., Satpathy, Ansuman T., Chang, Howard Y., Mackall, Crystal L.

Volltext

CD22-targeted CAR T cells induce remission in B-ALL that is naive or resistant to CD19-targeted CAR immunotherapy von Fry, Terry J, Shah, Nirali N, Orentas, Rimas J, Stetler-Stevenson, Maryalice, Yuan, Constance M, Ramakrishna, Sneha, Wolters, Pamela, Martin, Staci, Delbrook, Cindy, Yates, Bonnie, Shalabi, Haneen, Fountaine, Thomas J, Shern, Jack F, Majzner, Robbie G, Stroncek, David F, Sabatino, Marianna, Feng, Yang, Dimitrov, Dimiter S, Zhang, Ling, Nguyen, Sang, Qin, Haiying, Dropulic, Boro, Lee, Daniel W, Mackall, Crystal L

Volltext

CAR T Cells Targeting B7-H3, a Pan-Cancer Antigen, Demonstrate Potent Preclinical Activity Against Pediatric Solid Tumors and Brain Tumors von Majzner, Robbie G, Theruvath, Johanna L, Nellan, Anandani, Heitzeneder, Sabine, Cui, Yongzhi, Mount, Christopher W, Rietberg, Skyler P, Linde, Miles H, Xu, Peng, Rota, Christopher, Sotillo, Elena, Labanieh, Louai, Lee, Daniel W, Orentas, Rimas J, Dimitrov, Dimiter S, Zhu, Zhongyu, Croix, Brad St, Delaidelli, Alberto, Sekunova, Alla, Bonvini, Ezio, Mitra, Siddhartha S, Quezado, Martha M, Majeti, Ravindra, Monje, Michelle, Sorensen, Poul H B, Maris, John M, Mackall, Crystal L

Volltext

In vivo imaging of nanoparticle-labeled CAR T cells von Kiru, Louise, Zlitni, Aimen, Tousley, Aidan Michael, Dalton, Guillermo Nicolás, Wu, Wei, Lafortune, Famyrah, Liu, Anna, Cunanan, Kristen May, Nejadnik, Hossein, Sulchek, Todd, Moseley, Michael Eugene, Majzner, Robbie G, Daldrup-Link, Heike Elisabeth

Volltext

Tumor Antigen and Receptor Densities Regulate Efficacy of a Chimeric Antigen Receptor Targeting Anaplastic Lymphoma Kinase von Walker, Alec J., Majzner, Robbie G., Zhang, Ling, Wanhainen, Kelsey, Long, Adrienne H., Nguyen, Sang M., Lopomo, Paola, Vigny, Marc, Fry, Terry J., Orentas, Rimas J., Mackall, Crystal L.

Volltext

Assessment of programmed death‐ligand 1 expression and tumor‐associated immune cells in pediatric cancer tissues von Majzner, Robbie G., Simon, Jason S., Grosso, Joseph F., Martinez, Daniel, Pawel, Bruce R., Santi, Mariarita, Merchant, Melinda S., Geoerger, Birgit, Hezam, Imene, Marty, Virginie, Vielh, Phillippe, Daugaard, Mads, Sorensen, Poul H., Mackall, Crystal L., Maris, John M.

Volltext

CAR T cells with dual targeting of CD19 and CD22 in adult patients with recurrent or refractory B cell malignancies: a phase 1 trial von Spiegel, Jay Y., Patel, Shabnum, Muffly, Lori, Hossain, Nasheed M., Oak, Jean, Baird, John H., Frank, Matthew J., Shiraz, Parveen, Sahaf, Bita, Craig, Juliana, Iglesias, Maria, Younes, Sheren, Natkunam, Yasodha, Ozawa, Michael G., Yang, Eric, Tamaresis, John, Chinnasamy, Harshini, Ehlinger, Zach, Reynolds, Warren, Lynn, Rachel, Rotiroti, Maria Caterina, Gkitsas, Nikolaos, Arai, Sally, Johnston, Laura, Lowsky, Robert, Majzner, Robbie G., Meyer, Everett, Negrin, Robert S., Rezvani, Andrew R., Sidana, Surbhi, Shizuru, Judith, Weng, Wen-Kai, Mullins, Chelsea, Jacob, Allison, Kirsch, Ilan, Bazzano, Magali, Zhou, Jing, Mackay, Sean, Bornheimer, Scott J., Schultz, Liora, Ramakrishna, Sneha, Davis, Kara L., Kong, Katherine A., Shah, Nirali N., Qin, Haiying, Fry, Terry, Feldman, Steven, Mackall, Crystal L., Miklos, David B.

Volltext

Co-opting signalling molecules enables logic-gated control of CAR T cells von Tousley, Aidan M., Rotiroti, Maria Caterina, Labanieh, Louai, Rysavy, Lea Wenting, Kim, Won-Ju, Lareau, Caleb, Sotillo, Elena, Weber, Evan W., Rietberg, Skyler P., Dalton, Guillermo Nicolas, Yin, Yajie, Klysz, Dorota, Xu, Peng, de la Serna, Eva L., Dunn, Alexander R., Satpathy, Ansuman T., Mackall, Crystal L., Majzner, Robbie G.

Volltext

Tuning the Antigen Density Requirement for CAR T-cell Activity von Majzner, Robbie G., Rietberg, Skyler P., Sotillo, Elena, Dong, Rui, Vachharajani, Vipul T., Labanieh, Louai, Myklebust, June H., Kadapakkam, Meena, Weber, Evan W., Tousley, Aidan M., Richards, Rebecca M., Heitzeneder, Sabine, Nguyen, Sang M., Wiebking, Volker, Theruvath, Johanna, Lynn, Rachel C., Xu, Peng, Dunn, Alexander R., Vale, Ronald D., Mackall, Crystal L.

Volltext

Enhanced safety and efficacy of protease-regulated CAR-T cell receptors von Labanieh, Louai, Majzner, Robbie G., Klysz, Dorota, Sotillo, Elena, Fisher, Chris J., Vilches-Moure, José G., Pacheco, Kaithlen Zen B., Malipatlolla, Meena, Xu, Peng, Hui, Jessica H., Murty, Tara, Theruvath, Johanna, Mehta, Nishant, Yamada-Hunter, Sean A., Weber, Evan W., Heitzeneder, Sabine, Parker, Kevin R., Satpathy, Ansuman T., Chang, Howard Y., Lin, Michael Z., Cochran, Jennifer R., Mackall, Crystal L.

Volltext